Immune dysregulation: an “accelerator” of gut resistome expansion and multidrug-resistant organism infection risk in ICU patients
- 1Department of Intensive Care Medicine, The Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People's Hospital, The Wenzhou People's Hospital Affiliated of Hangzhou Medical College
- 2Department of Infectious Diseases, Taishun People’s Hospital
Abstract
Immune dysregulation is a common and critical condition in intensive care unit (ICU) patients, significantly increasing their susceptibility to infections. Beyond heightened vulnerability, immune dysfunction plays a pivotal role in accelerating the expansion of antibiotic resistance genes (ARGs) within the gut microbiome, thereby promoting the emergence and proliferation of multidrug-resistant organisms (MDROs). This review systematically examines the mechanisms by which immune dysregulation acts as a key “accelerator” driving the amplification of the gut resistome in ICU patients and explores the intrinsic link between this process and the elevated risk of MDRO infections. We analyze multiple dimensions including immune suppression-induced gut microbial imbalance, inflammation-mediated horizontal gene transfer (HGT), antibiotic pressure fostering selective advantages, and clinical intervention strategies. Integrating the latest advances in metagenomics and immunology, this article aims to provide novel theoretical insights and clinical guidance for infection prevention and control in the ICU setting. By elucidating the central role of immune dysregulation in ARG expansion, we emphasize the necessity of precise immune modulation combined with targeted anti-infective approaches to reduce MDRO infection risk and improve patient outcomes in critical care.
Related
- Genomic insights into population structure, resistome, virulome, and mobilome of multidrug-resistant Pseudomonas aeruginosa
- Natural and engineered bacteriophages against multidrug-resistant ESKAPE pathogens: current landscape and clinical translation
- Comparative antibacterial, synergistic, and anti-biofilm efficacy of metal ions against multidrug-resistant pathogens on dairy equipment surfaces
- A virulent and temperate phage cocktail synergizes with antibiotics against multidrug-resistant Pseudomonas aeruginosa
- ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections
BibTeX
@article{xu2026immune,
title = {{Immune dysregulation: an “accelerator” of gut resistome expansion and multidrug-resistant organism infection risk in ICU patients}},
author = {Rujie Xu and Feimeisi Zhou and Kaihuai Wu and Xiaojie Wang and Yu Li and Saimiao Hou},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1895928},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1895928/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Immune dysregulation: an “accelerator” of gut resistome expansion and multidrug-resistant organism infection risk in ICU patients
AU - Rujie Xu
AU - Feimeisi Zhou
AU - Kaihuai Wu
AU - Xiaojie Wang
AU - Yu Li
AU - Saimiao Hou
PY - 2026
DA - 2026/11/12
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1895928
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1895928/full
AB - Immune dysregulation is a common and critical condition in intensive care unit (ICU) patients, significantly increasing their susceptibility to infections. Beyond heightened vulnerability, immune dysfunction plays a pivotal role in accelerating the expansion of antibiotic resistance genes (ARGs) within the gut microbiome, thereby promoting the emergence and proliferation of multidrug-resistant organisms (MDROs). This review systematically examines the mechanisms by which immune dysregulation acts as a key “accelerator” driving the amplification of the gut resistome in ICU patients and explores the intrinsic link between this process and the elevated risk of MDRO infections. We analyze multiple dimensions including immune suppression-induced gut microbial imbalance, inflammation-mediated horizontal gene transfer (HGT), antibiotic pressure fostering selective advantages, and clinical intervention strategies. Integrating the latest advances in metagenomics and immunology, this article aims to provide novel theoretical insights and clinical guidance for infection prevention and control in the ICU setting. By elucidating the central role of immune dysregulation in ARG expansion, we emphasize the necessity of precise immune modulation combined with targeted anti-infective approaches to reduce MDRO infection risk and improve patient outcomes in critical care.
SN - 1664-3224
ER -